NASDAQ
No price data available for this timeframe.
Galectin Therapeutics Inc. (GALT) has a total debt of $133.74M as of Wednesday, December 31, 2025. Total debt represents the sum of a company's short-term and long-term borrowings, indicating its overall leverage and financial obligations.